SCLC Treatment - Limited Disease

Combined Modality Therapy for Limited-Stage SCLC (Medscape)
Hak Choy, MD, discusses the treatment goals and options in Limited-Stage SCLC. These CME modules are aimed at physicians. Registration required for free access to Medscape. [4/02]

Limited Small Cell Lung Cancer: A Potentially Curable Disease (cancernetwork.com)
by Carol A. Sherman, MD, et al.
v.14, no.10 ONCOLOGY (October 2000):1395-1409
Reviews the current treatment approach to limited-stage small cell carcinoma, describes ongoing trials, and explores future directions. Registration required for free access. [10/00]

SCLC: Limited disease - Recent MEDLINE Abstracts (PubMed)

Limited Small Cell Lung Cancer: Etoposide and Cisplatin Plus Paclitaxel May Offer Prolonged Survival Time (OnTumor.com)
Describes a multicenter study (reported in the Journal of Clinical Oncology, v.18, no.5, 2000) that found the addition of paclitaxel to etoposide and cisplatin may improve treatment results. [4/00]

Phase II Trial of Paclitaxel, Cisplatin, and Etoposide with Concurrent Radiation for Limited-Stage Small Cell Lung Cancer (Journal of Clinical Oncology)
Abstract of a study (reported in the Journal of Clinical Oncology, v.19,
no.15, August 2001) that found the addition of paclitaxel to cisplatin/etoposide chemotherapy and concurrent thoracic radiotherapy in the treatment of limited stage SCLC is effective, well- tolerated, and compares favorably with previous phase II studies. [8/01]

Treating Limited-stage SCLC? (Medscape)
Vincent Miller, MD, recommends treatment for a 48 year-old man presumed to have limited SCLC. Aimed at physicians. Registration required for free access to Medscape. [7/03]

Treating Super-Limited SCLC? (Medscape)
Case study, presented by Corey J. Langer, MD, that addresses the real, but limited role for surgery in super-limited SCLC. [7/02]